Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seminoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Medulloblastoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hearing Loss 1Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 8Specimen Handling 7Cisplatin 7Surgical Procedures, Operative 5pembrolizumab 3Radiotherapy, Intensity-Modulated 3Platinum 3Chemoradiotherapy 3Cetuximab 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3Radiotherapy 2Radiation 2Interviews as Topic 2Docetaxel 2toripalimab 1sacituzumab govitecan 1merphos 1ipatasertib 1cabozantinib 1X-Rays 1Tretinoin 1Surveys and Questionnaires 1Standard of Care 1Radiotherapy, Image-Guided 1Radiosurgery 1Practice Guidelines as Topic 1Nivolumab 1Neoadjuvant Therapy 1Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hypopharyngeal Neoplasms × Hearing × Clear all
NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡